Zaineb Daud, MD
Neurology · Philadelphia, MSNPI 1568468908
Payments from drug & device makers
Across 446 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acadia Pharmaceuticals Inc$1K
- Lilly USA, LLC$938
- Teva Pharmaceuticals USA, Inc.$732
- Pfizer$570
- SK Life Science, Inc.$540
- Novartis$412
- plus $4K from 34 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$8,191 in reported general payments places this provider in the 60th percentile of 111 neurology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Philadelphia
- Ronald SchwartzHattiesburg$5.6M
- Stephen LandyTupelo$1.9M
- Ruth FredericksJackson$943K
- Wendell HelvestonJackson$883K
- Paul BradleyMeridian$456K
- Juebin HuangJackson$231K
- Rajesh SharmaJackson$152K
- Paula WarrenHattiesburg$114K
- Justin GraffTupelo$85K
- Patrick WeldonJackson$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.